Application of timing option to founding investment decision of biotech start-ups
In the field of life sciences, biotech start-ups are expected to follow a more rapid commercialization process than that experienced by big pharmaceutical companies. There are about 300 public companies out of 1500 biotech start-ups in the United States, but only 23 public companies out of about 500...
| Verfasser: | |
|---|---|
| Dokumenttypen: | Artikel |
| Medientypen: | Text |
| Erscheinungsdatum: | 2011 |
| Publikation in MIAMI: | 06.08.2012 |
| Datum der letzten Änderung: | 01.09.2022 |
| Quelle: | Journal of Business Chemistry, 8 (2011) 3, S. 133-146 |
| Angaben zur Ausgabe: | [Electronic ed.] |
| Fachgebiet (DDC): | 330: Wirtschaft |
| Lizenz: | InC 1.0 |
| Sprache: | English |
| Anmerkungen: | Section "Research Paper" |
| Format: | PDF-Dokument |
| URN: | urn:nbn:de:hbz:6-69379462121 |
| Permalink: | https://nbn-resolving.de/urn:nbn:de:hbz:6-69379462121 |
| Onlinezugriff: | 2011_vol-8_iss3_133-146.pdf |
Wird geladen...